Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Apetiviton BC
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Apetiviton BC is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anorexia.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 15, 2010
Lead Product(s) : Apetiviton BC
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable